This episode currently has no reviews.
Submit ReviewAbbott Labs and Bed Bath & Beyond both deliver better-than-expected quarterly results. CEO Oscar Munoz shares United Airlines’ plan to cut flights in May. Costco boosts its quarterly dividend. Ron Gross analyzes those stories, as well as Verizon getting into the video conferencing business with its acquisition of BlueJeans Network. We also discuss why we’re rooting for Abbott Labs and Medtronic, and an idea for our newest basket of stocks.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review